⌘K

Login Start Free

Home/Filings/4/0001178913-10-002258

4//SEC Filing

Boim Aviv 4

Accession 0001178913-10-002258

CIK 0001451980other

View on SEC.gov Company Profile

Filed

Aug 29, 8:00 PM ET

Accepted

Aug 30, 8:17 AM ET

Size

11.7 KB

Accession

0001178913-10-002258

Insider Transaction Report

Form 4

Period: 2010-03-25

BIOCANCELL THERAPEUTICS INC.BICL.TA

Director

Transactions

Award
Warrant to Purchase Common Stock
2008-07-30+4,301,906→ 4,301,906 total(indirect: By Tikcro Technologies Ltd.)
Exercise: $0.72From: 2008-07-30Exp: 2013-07-30→ Common Stock, par value $0.01 (4,301,906 underlying)
Award
Note Convertible into Common Stock
2008-07-30$2000000.00/sh+3,464,385$6,928,770,000,000→ 3,464,385 total(indirect: By Tikcro Technologies Ltd.)
Exercise: $0.72From: 2008-07-30Exp: 2012-07-30→ Common Stock, par value $0.01 (3,464,385 underlying)
Purchase
Common Stock, par value $0.01
2008-07-31$500000.00/sh+800,463$400,231,500,000→ 800,463 total(indirect: By Tikcro Technologies Ltd.)
Award
Option to Purchase Common Stock
2010-03-25+20,000→ 20,000 total
Exercise: $0.85Exp: 2020-03-25→ Common Stock, par value $0.01 (20,000 underlying)

Footnotes (2)

[F1]The reporting person may be deemed to have a pecuniary interest in such securities pursuant to an agreement with the holder thereof, Tikcro Technologies Ltd.
[F2]10,000 options shall vest and be exercisable on each of September 25, 2010 and March 25, 2011.

Documents

1 file

4
a1008587_ex.xmlPrimary

Issuer

BIOCANCELL THERAPEUTICS INC.

CIK 0001451980

Entity typeother

Related Parties

1

filerCIK 0001438715

Filing Metadata

Form type: 4
Filed: Aug 29, 8:00 PM ET
Accepted: Aug 30, 8:17 AM ET
Size: 11.7 KB

View on SEC.gov